What is Tebra?
Headquartered in Irvine, California, Tebra operates as a comprehensive healthcare platform designed to streamline the intersection of clinical operations and patient interaction. The company specializes in providing a suite of digital tools that empower medical practices to optimize their workflows, improve patient outcomes, and simplify administrative burdens. By focusing on the patient experience, Tebra addresses critical pain points in the healthcare delivery system, positioning itself as an essential partner for modern, tech-enabled medical providers. Its market position is defined by a commitment to interoperability and user-centric design, which are vital for scaling in the complex U.S. healthcare market.
How much funding has Tebra raised?
Tebra has raised a total of $322M across 2 funding rounds:
Other Financing Round
$72M
Debt
$250M
Other Financing Round (2022): $72M with participation from Golub Capital
Debt (2025): $250M led by Transformation Capital, HLM Venture Partners, Toba Capital, Hildred, and JP Morgan & Co
Key Investors in Tebra
Transformation Capital
A growth equity fund headquartered in Boston, Massachusetts, that is fully focused on supporting innovative healthcare IT and services companies.
HLM Venture Partners
A specialized investment firm that partners with visionary founders to build enduring companies in the healthcare technology and services sectors.
Toba Capital
An investment firm based in California that focuses on early-stage technology companies with long-term growth potential, particularly within the SaaS and IT infrastructure spaces.
What's next for Tebra?
Looking ahead, Tebra is well-positioned to leverage this major enterprise-level funding to drive long-term growth and innovation. The strategic focus will likely center on deepening its software capabilities, potentially through enhanced data analytics, automated patient communication, and expanded integration with existing electronic health record systems. As the healthcare industry continues its digital transformation, Tebra's ability to deploy this capital effectively will be crucial in maintaining its competitive edge. Investors are clearly betting on the company's capacity to redefine the standard of care through technology, with the recent financing providing the stability required to pursue aggressive market expansion and product diversification in the coming fiscal periods.
See full Tebra company page
